These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation. Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205 [TBL] [Abstract][Full Text] [Related]
23. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies. Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624 [TBL] [Abstract][Full Text] [Related]
24. Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors. Dubois C; Bissonnette E; Rola-Pleszczynski M J Immunol; 1989 Aug; 143(3):964-70. PubMed ID: 2545780 [TBL] [Abstract][Full Text] [Related]
25. Effect of SR 27417 on the binding of [3H]PAF to rabbit and human platelets and human polymorphonuclear leukocytes. Herbert JM; Laplace MC; Cailleau C; Maffrand JP J Lipid Mediat; 1993 May; 7(1):57-78. PubMed ID: 8395255 [TBL] [Abstract][Full Text] [Related]
27. Downregulation of platelet-activating factor responsiveness during maturation of human dendritic cells. Dichmann S; Rheinen H; Panther E; Herouy Y; Czech W; Termeer C; Simon JC; Gebicke-Haerter PJ; Norgauer J J Cell Physiol; 2000 Dec; 185(3):394-400. PubMed ID: 11056009 [TBL] [Abstract][Full Text] [Related]
28. Platelet-activating factor induces an increase in intracellular calcium and expression of regulatory genes in human B lymphoblastoid cells. Mazer B; Domenico J; Sawami H; Gelfand EW J Immunol; 1991 Mar; 146(6):1914-20. PubMed ID: 1848574 [TBL] [Abstract][Full Text] [Related]
29. Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing. Ma X; Bazan HE Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1696-702. PubMed ID: 10845588 [TBL] [Abstract][Full Text] [Related]
30. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor. Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114 [TBL] [Abstract][Full Text] [Related]
31. Picomolar platelet-activating factor mobilizes Ca to change platelet shape without activating phospholipase C or protein kinase C; simultaneous fluorometric measurement of intracellular free Ca concentration and aggregation. James-Kracke MR; Sexe RB; Shukla SD J Pharmacol Exp Ther; 1994 Nov; 271(2):824-31. PubMed ID: 7965802 [TBL] [Abstract][Full Text] [Related]
32. Up-regulation of platelet-activating factor receptors in lung and alveolar macrophages in the bleomycin-hamster model of pulmonary fibrosis. Chen J; Ziboh V; Giri SN J Pharmacol Exp Ther; 1997 Mar; 280(3):1219-27. PubMed ID: 9067307 [TBL] [Abstract][Full Text] [Related]
33. Further characterization of PAF receptor and novel antagonists. Shen TY; Hussaini I Int J Tissue React; 1990; 12(2):63-9. PubMed ID: 2170286 [TBL] [Abstract][Full Text] [Related]
34. Specific binding sites of platelet activating factor on the intact bovine cerebral microvascular endothelial cells and antagonism of drugs. Sun DX; Rui YC; Zeng GQ; Zhu J; Shen YA Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):326-9. PubMed ID: 1333718 [TBL] [Abstract][Full Text] [Related]
35. [Inhibitory effect of kaempferol against binding of platelet activating factor to its receptor]. Zang BX; Jin M; Wu W; Chen WM; Piao YZ; Li JR Zhongguo Zhong Yao Za Zhi; 2004 Aug; 29(8):789-91. PubMed ID: 15506296 [TBL] [Abstract][Full Text] [Related]
36. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731. Doebber TW; Wu MS; Biftu T J Immunol; 1986 Jun; 136(12):4659-68. PubMed ID: 3011900 [TBL] [Abstract][Full Text] [Related]
37. Characterization of receptors for platelet-activating factor in guinea pig lung membranes. Gomez J; Bloom JW; Yamamura HI; Halonen M Am J Respir Cell Mol Biol; 1990 Sep; 3(3):259-64. PubMed ID: 2167700 [TBL] [Abstract][Full Text] [Related]
38. Platelet-activating factor acts on cortisol secretion by perfused guinea-pig adrenals via calcium-/phospholipid-dependent mechanisms. Shimada T; Hirose T; Matsumoto I; Aikawa T J Endocrinol; 2005 Feb; 184(2):381-91. PubMed ID: 15684346 [TBL] [Abstract][Full Text] [Related]
39. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor. Hwang SB; Lam MH; Alberts AW; Bugianesi RL; Chabala JC; Ponpipom MM J Pharmacol Exp Ther; 1988 Aug; 246(2):534-41. PubMed ID: 2841449 [TBL] [Abstract][Full Text] [Related]